FDA says it will publish reports of adverse events tied to drugs on daily basis

What's new in pharma

August 22, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | FDA says it will publish reports of adverse events tied to drugs on daily basis Changes to the FAERS database, previously updated quarterly, reflect the commissioner's focus on post-market surveillance. By Lizzy Lawrence Viking's obesity flop, 'pharma to table' drug sales We discuss why direct-to-consumer plans championed by Eli Lilly, Novo Nordisk, and others are unlikely to make drugs more affordable. By Adam Feuerstein, Elaine Chen, and Allison DeAngelis STAT+ | FDA approves Ionis drug that prevents swelling attacks caused by a rare disease Ionis faces stiff competition from Takeda, which markets the blockbuster Takhzyro, and the BioCryst Pharmaceuticals drug Orladeyo By Jonathan Wosen Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser